How to Cite
Abstract
The article represents a narrative review on pain management through safe use of medications during pregnancy. It represents an update on the current state of the pharmacological management of pain in pregnant women. More than 20 recent studies in the clinical field were reviewed, published on widely disseminated platforms such as Chocrane, Medline, ScienceDirect, Springer, among others. Approaches to the treatment of pain in pregnant women are described. A general description is made of non-pharmacological management, with emphasis on physical therapy. The main safe medications for pain management in pregnancy are broadly described. The use of paracetamol stands out as the main recommended in the first two trimesters. Weakly effective opioids are recommended throughout the process, especially buprenorphine. Metoclopramide and triptans are recommended for migraine. Pain management must be done with rigorous criteria, taking into account the patient's history and the proven suitability of the medication for the stage of pregnancy. The possible risks must be weighed against the expected benefits.
Keywords
References
Héctor Lacassie Q. Dolor y Embarazo. Revista Médica Clínica Las Condes. 1o de julio, 2014;25(4):641-50.
Rivera Díaz R, Lopera Rivera A. Management of non-obstetric pain during pregnancy. Colombian Journal of Anestesiology. Oct, 2012;40(3):213-23.
Ashburn MA, Staats PS. Management of chronic pain. The Lancet. May 29, 1999;353(9167):1865-9.
Haefeli M, Elfering A. Pain assessment. Eur Spine J. Jan 2006;15(Suppl 1):S17-24.
Bauchat J, Wong CA. Pain management during pregnancy and lactation. In: Essentials of pain medicine [Internet]. Elsevier; 2018 [cited Jul 05, 2024]:339-44. Available from: https://www.sciencedirect.com/science/article/pii/B9780323401968000395
Wells RE, Turner DP, Lee M, Bishop L, Strauss L. Managing Migraine During Pregnancy and Lactation. Curr Neurol Neurosci Rep. Apr, 2016;16(4):40.
Guzmán Carrasco P, Díaz López AM, Gómez López D, Guzmán Carrasco R, Guzmán Carrasco Á. Actuación del fisioterapeuta en el tratamiento integral de la embarazada. NURE investigación: Revista Científica de Enfermería. 2013;(63):6.
Sáez García M del C. Fisioterapia para el dolor lumbopélvico en el embarazo. Revisión sistemática cualitativa. 2015 [citado el 05 de julio, 2024]. Disponible a partir de: https://ebuah.uah.es/dspace/handle/10017/22095
Gómez Milán AM. Fisioterapia en el embarazo, parto y postparto. 2020 [citado el 05 de julio, 2024]. Disponible a partir de: https://gredos.usal.es/handle/10366/144109
De Fays L, Van Malderen K, De Smet K, Sawchik J, Verlinden V, Hamdani J, et al. Use of paracetamol during pregnancy and child neurological development. Developmental Medicine & Child Neurology. 2015;57(8):718-24.
Croen LA, Qian Y, Ashwood P, Zerbo O, Schendel D, Pinto-Martin J, et al. Infection and Fever in Pregnancy and Autism Spectrum Disorders: Findings from the Study to Explore Early Development. Autism Res. Oct, 2019;12(10):1551-61.
Graham JM. Update on the gestational effects of maternal hyperthermia. Birth Defects Res. Jul 15, 2020;112(12):943-52.
Ennis ZN, Dideriksen D, Vaegter HB, Handberg G, Pottegård A. Acetaminophen for Chronic Pain: A Systematic Review on Efficacy. Basic Clin Pharmacol Toxicol. Mar, 2016;118(3):184-9.
Engelstoft IMS, Carlsen LN, Munksgaard SB, Nielsen M, Jensen RH, Bendtsen L. Complete withdrawal is the most feasible treatment for medication-overuse headache: A randomized controlled open-label trial. Eur J Pain. Jul, 2019;23(6):1162-70.
Bauer AZ, Swan SH, Kriebel D, Liew Z, Taylor HS, Bornehag CG, et al. Paracetamol use during pregnancy — a call for precautionary action. Nat Rev Endocrinol. Dec, 2021;17(12):757-66.
Antonucci R, Zaffanello M, Puxeddu E, Porcella A, Cuzzolin L, Pilloni MD, et al. Use of non-steroidal anti-inflammatory drugs in pregnancy: impact on the fetus and newborn. Curr Drug Metab. May 01, 2012;13(4):474-90.
Kassaw C, Wabe NT. Pregnant Women and Non-Steroidal Anti-Inflammatory Drugs: Knowledge, Perception and Drug Consumption Pattern During Pregnancy in Ethiopia. N Am J Med Sci. Feb, 2012;4(2):72-6.
Research C for DE and. FDA recommends avoiding use of NSAIDs in pregnancy at 20 weeks or later because they can result in low amniotic fluid. FDA [Internet]. Dec 01, 2022 [cited Jul 05, 2024]; Available from: https://www.fda.gov/drugs/fda-drug-safety-podcasts/fda-recommends-avoiding-use-nsaids-pregnancy-20-weeks-or-later-because-they-can-result-low-amniotic
Marhofer D, Jaksch W, Aigmüller T, Jochberger S, Urlesberger B, Pils K, et al. Schmerztherapie in der Schwangerschaft: Eine expertInnenbasierte interdisziplinäre Konsensus-Empfehlung. Der Schmerz [Internet]. 2021 [cited Jul 05, 2024]. Available from: https://people.fh-burgenland.at/handle/20.500.11790/1856
Meyer MC, Johnston AM, Crocker AM, Heil SH. Methadone and buprenorphine for opioid dependence during pregnancy: A retrospective cohort study. J Addict Med. 2015;9(2):81-6.
Brandes JL. Headache related to pregnancy: Management of migraine and migraine headache in pregnancy. Curr Treat Options Neurol. Jan, 2008;10(1):12-9.
Jarvis S, Dassan P, Piercy CN. Managing migraine in pregnancy. Bmj [Internet]. 2018 [cited Jul 05, 2024];360. Available from: https://www.bmj.com/content/360/bmj.k80.full
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright (c) 2024 Array